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Membrane contact sites between the ER and multi-
vesicular endosomes/bodies (MVBs) play important
roles in endosome positioning and fission and in
neurite outgrowth. ER-MVB contacts additionally
function in epidermal growth factor receptor
(EGFR) tyrosine kinase downregulation by pro-
viding sites where the ER-localized phosphatase,
PTP1B, interacts with endocytosed EGFR before
the receptor is sorted onto intraluminal vesicles
(ILVs). Here we show that these contacts are teth-
ered by annexin A1 and its Ca2+-dependent ligand,
S100A11, and form a subpopulation of differentially
regulated contact sites between the ER and endo-
cytic organelles. Annexin A1-regulated contacts
function in the transfer of ER-derived cholesterol
to the MVB when low-density lipoprotein-choles-
terol in endosomes is low. This sterol traffic de-
pends on interaction between ER-localized VAP
and endosomal oxysterol-binding protein ORP1L,
and is required for the formation of ILVs within the
MVB and thus for the spatial regulation of EGFR
signaling.
INTRODUCTION
The ER forms an extensive network of membrane contact sites
(MCSs), microdomains of close membrane apposition
(<30 nm), with a diverse range of functionally distinct organ-
elles, providing an important means of non-vesicular commu-
nication between organelles. Although only recently described
(Eden et al., 2010; Rocha et al., 2009), MCSs between the ER
and the endocytic pathway are extremely abundant (Friedman
et al., 2013; Kilpatrick et al., 2013), suggesting important phys-
iological roles (Raiborg et al., 2015b). Indeed functions in
endosomal positioning (Rocha et al., 2009) and defining the
timing and position of endosome fission during cargo sorting
(Rowland et al., 2014) have been reported. ER-endosome
MCSs were also recently found to mediate endosome translo-
cation to and fusion with the plasma membrane, promoting
protrusion and neurite outgrowth (Raiborg et al., 2015a).
MCSs provide sites of interaction for the ER-localized phos-Developmental Cell 37, 473–483,
This is an open access article undphatase, PTP1B, with endocytosed epidermal growth factor
receptor (EGFR) and components of the endosomal sorting
complex required for transport (ESCRT) machinery (Eden
et al., 2010; Stuible et al., 2010). PTP1B activity dampens
EGFR signaling, not only by dephosphorylating the EGFR,
but also by promoting EGF-stimulated intraluminal vesicle
(ILV) formation (Eden et al., 2010), a process that sequesters
the catalytic domain of the receptor from cytoplasmic sub-
strates prior to lysosomal degradation.
The molecular composition of ER contacts with the endo-
cytic pathway remains poorly understood, hampering func-
tional studies. MCSs are stabilized by tethering complexes
that maintain close proximity between apposing membranes.
Vesicle-associated membrane protein-associated proteins
(VAPs) are conserved ER membrane proteins that recruit
binding partners to multiple MCSs between the ER and other
organelles (Prinz, 2014) by binding FFAT motifs, which are pre-
dominantly found in lipid transfer proteins (Loewen and Levine,
2005). Two sterol-binding proteins, ORP1L (Rocha et al., 2009)
and STARD3 (Alpy et al., 2013), that both contain FFAT motifs,
interact with VAP at MCSs between the ER and endosomes.
ORP1L is recruited to Rab7-positive late endosomes, distinct
from the earlier endosomes that stain for STARD3 (van der
Kant et al., 2013), while both early and late EGFR-containing
multivesicular endosomes/bodies (MVBs) can form MCSs
with the ER (Eden et al., 2010), together suggesting the exis-
tence of multiple populations of MCS between the ER and en-
docytic organelles. We previously showed that EGFR traffics in
a subpopulation of MVBs in which annexin A1 promotes ILV
formation by an unknown mechanism (White et al., 2006). An-
nexin A1 is a substrate of EGFR tyrosine kinase (Gerke and
Moss, 2002) and can mediate membrane aggregation in vitro
(Blackwood and Ernst, 1990) and so is itself a candidate
tether. We hypothesized that annexin A1’s primary role at
the MVB could be in MCS formation, which in turn is required
for ILV formation. MCSs likely facilitate ILV formation by allow-
ing PTP1B interaction with endosomal ESCRT proteins (Eden
et al., 2010; Stuible et al., 2010). Here we demonstrate the
presence of multiple biochemically distinct MCSs between
the ER and endocytic organelles. Annexin A1 is a key regulator
of both ER contacts with EGFR-positive MVBs and EGF-stim-
ulated ILV formation, a process that we find requires choles-
terol. When there is not enough cholesterol in the endocytic
pathway, annexin A1-regulated MCSs are required for
ORP1L/VAP-dependent transport of ER-derived cholesterol
to MVBs to support ILV formation.June 6, 2016 ª 2016 The Author(s). Published by Elsevier Inc. 473
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RESULTS
Annexin A1 Tethers a Subpopulation of Differentially
Regulated MCSs between the ER and Endocytic
Organelles that Provide Sites for PTP1B-EGFR
Interaction
We have used electron microscopy (EM) to unequivocally iden-
tify MCSs, while also allowing the distinction between MVBs
(containing discrete ILVs) and electron-dense lysosomes (Fig-
ure 1A). Co-incubating EGF-stimulated cells with an antibody
to the EGFR extracellular domain coupled to gold allows
EGFR-containing and non-EGFR-containing MVB subpopula-
tions to be distinguished (Figure 1A). AlthoughMCSswith a given
MVBmay not be in the plane of a random section, we foundMCS
quantification in random sections to be comparable with that
achieved by serial sectioning (Figure S1A). Focusing first on
the potential role of the VAP-ORP1L interaction, we found that
ER contacts with EGFR-MVBs were unaffected by VAP deple-
tion, but MCSs with non-EGFR-MVBs and lysosomes were
reduced by approximately 50% (Figures 1B and S1B). This
shows that more than one population of MCSs exists between
the ER and endocytic organelles. Consistent with a role for
VAPs in tethering MCSs between the ER and both non-EGFR-
MVBs and lysosomes, we found that cfp-VAPA localized to the
ER including sites of contact with both these organelles (Fig-
ure S1C). Surprisingly, MCS formation was not impaired in cells
depleted of ORP1L, but MCSs with EGFR-MVBs were increased
(Figures 1B and S1B). As previously reported (Rocha et al.,
2009), ER-endosome MCSs were increased when cells were
cultured in lipoprotein-deficient serum (LPDS), conditions which
favor VAP-ORP1L interaction. However, this effect was confined
to the subpopulation of MCSs with EGFR-MVB (Figure 1B),
although the already high percentage of non-EGFR-MVBs and
lysosomes with an MCS might render further potential increases
difficult to discern. Nevertheless, our data suggest that EGFR-
MVBs have a requirement for cholesterol that is revealed when
cells are deprived of exogenous lipoprotein.
In contrast to the effects of VAP depletion, when we depleted
cells of annexin A1, MCSs between the ER and EGFR-MVBs
were considerably reduced (Figures 1C and S1B). ER contacts
with both non-EGFR-MVBs and lysosomes were unaffected,
confirming the existence of multiple biochemically distinct
populations of ER-endocytic organelle MCSs. The loss of ER
contacts with EGFR-MVBs on annexin A1 depletion was accom-
panied by increased and prolonged EGFR tyrosine phosphoryla-
tion (Figures 1D and 1E). This was not observed in cells depletedFigure 1. Role of VAPs, ORP1L, and Annexin A1 in MCSs between the
(A and B) HeLa cells transfected with non-targeting siRNA (siCON) or siRNA target
were stimulated with EGF and anti-EGFR gold (30 min). ER MCSs (arrows) with e
three experiments. Scale bar, 200 nm.
(C) As (B), with siRNA targeting annexin A1 (siANXA1). ns, not significant p > 0.0
(D and E) HeLa cells transfected with non-targeting siRNA (siCON) or siRNA targe
blotted with antibodies to phosphotyrosine(pY)1068 or total EGFR (D), and quan
(F) HeLa cells transfected with WT annexin A1-gfp and mutant (D181A) PTP1B-
embedding labeling. GFP (white arrows) is visible at MCSs (black arrows) betwee
product. Scale bar, 200 nm.
(G) HeLa cells transfected with annexin A1-gfp and D181APTP1B-myc were stim
with anti-myc (10 nm gold) and anti-gfp (15 nm gold). Scale bar, 200 nm.
See also Figure S1.of ORP1L or VAPs (Figures S1D and S1E). Moreover, the accel-
erated EGFR tyrosine dephosphorylation observed in cells sta-
bly overexpressing wild-type (WT) PTP1BMyc (Eden et al.,
2010) was lost on depletion of annexin A1 (Figure S1F), suggest-
ing that annexin A1-regulated MCSs provide sites for PTP1B-
mediated EGFR dephosphorylation. We next determined
whether annexin A1 co-localizes with PTP1B at MCSs, taking
advantage of our previous demonstration that expression of a
substrate-trapping (D181A) mutant PTP1B causes the formation
of extended contacts between the ER and EGFR-MVBs (Eden
et al., 2010). Localization of annexin A1-gfp by pre-embedding
labeling, identifying PTP1B-containing MCSs by virtue of their
size (Figure 1F), or by cryo-immunoEM (Figure 1G), showed
that annexin A1 was present at MCSs between the ER and
EGFR-MVBs. Annexin A1 also localized at and proximal to the
point of contact between the ER and MVBs in the absence of
mutant PTP1B expression (Figure S1G). These data indicate a
direct role for annexin A1 in tethering the two membranes at
MCSs required for PTP1B-mediated EGFR dephosphorylation.
Correlation between Annexin A1-Regulated MCS
Formation and EGF-Stimulated ILV Formation
Wepreviously demonstrated that annexin A1 is required for EGF-
stimulated ILV formation (White et al., 2006), but the mechanism
whereby it promotes this ESCRT-dependent process is unclear.
Although manipulating PTP1B expression dramatically affects
ILV formation, it has only small effects on MCS formation
(Eden et al., 2010), suggesting that PTP1B’s role in ILV formation
is throughmodulating endosomal ESCRT or EGFR phosphoryla-
tion. However, the marked reduction in MCS formation upon
annexin A1 depletion suggests that annexin A1’s main role in
ILV formation could be through MCS formation. In this case,
modulating annexin A1 activity should affect both MCS and ILV
formation. Annexin A1 can form a Ca2+-dependent heterote-
tramer with S100A11 (Rety et al., 2000) so we determined the
intracellular distribution of S100A11. Its predominant ER locali-
zation, including at MCSs between the ER andMVBs (Figure 2A),
raised the possibility that its interaction with endosomal annexin
A1 might bridge the two membranes at the contact. Consis-
tently, depletion of S100A11 (Figure S2A) or treatment with the
cell-permeable calcium chelator, BAPTA-AM, severely disrup-
ted ER contacts with EGFR-MVBs (Figure 2B). Furthermore,
the same treatments severely disrupted EGF-stimulated ILV
formation (Figure 2C), revealing a striking correlation between
MCS and ILV formation. S100A11 depletion also resulted in
increased and prolonged EGFR tyrosine phosphorylationER and Different Endocytic Organelles
ing VAPA and VAPB (siVAPs) or ORP1L (siORP1L) or cultured overnight in LPDS
ndocytic organelles (examples in A) were quantified (B). Data are mean ± SD of
5; **p < 0.01.
ting annexin A1 (siANXA1) were stimulated with EGF as indicated, cell lysates
tified (E). Data are mean ± SD of three experiments.
myc were stimulated with EGF-HRP (60 min) and stained for GFP using pre-
n the ER and EGFR-MVBs containing electron-dense EGF-HRP DAB reaction
ulated with EGF and anti-EGFR-5 nm gold (30 min). Cryosections were labeled
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(Figures S2B and S2C), consistent with a role for annexin
A1/S100A11 interactions in tethering MCSs that provide sites
for PTP1B-mediated effects at the endosome.
We previously showed that EGF-stimulated ILV formation
could be restored in annexin A1 knockout cells by overexpres-
sion of WT but not a tyrosine phosphorylation mutant of annexin
A1 (Y21F) (White et al., 2006). Therefore, to further probe the
requirements for MCS and ILV formation, we expressed phos-
phorylation mutant annexin A1 constructs (Figure S2D). Overex-
pression of WT annexin A1 increased ILVs/EGFR-MVB, as did
phosphomimetic Y21E-annexin A1, although this did not reach
statistical significance. Expression of Y21F-annexin A1 (that
cannot be tyrosine phosphorylated) had no effect on ILV forma-
tion (Figures 2D and 2E). Importantly, WT and phosphomimetic,
but not phosphorylation mutant annexin A1, also increased ER
MCSs with EGFR-MVBs (Figures 2D and 2F), correlating with
the effects of the same constructs on ILV formation (Figure 2E).
This suggests that EGF-stimulated annexin A1 phosphorylation
is necessary for its role in MCS formation. In addition, we found
an interaction between EGFR and annexin A1 after 10min of EGF
stimulation that was undetectable after 15 min stimulation (Fig-
ure S2E), consistent with annexin A1 tyrosine phosphorylation
occurring prior to MCS formation.
Overall these data show that the requirements for MCS and
EGF-stimulated ILV formation are similar, consistent with our
hypothesis that annexin A1/S100A11 tether MCSs that provide
sites for PTP1B-mediated effects on ILV formation.
EGF-Stimulated ILV Formation Requires Cholesterol
fromEndocytosis of LDL or fromAnnexin A1-Dependent
Transport from the ER
As MVBs mature, the number of ILVs increases. Since ILVs are
rich in cholesterol (Mobius et al., 2003), we hypothesized that,
just as plasmamembrane cholesterol is required for endocytosis
(Kozik et al., 2013), cholesterol-rich membrane may be required
for ILV formation. The source of the cholesterol could be either
exogenous sterols taken up via endocytosis of low-density lipo-
protein (LDL) that is hydrolyzed in the endocytic pathway to
release free cholesterol, or de novo synthesis in the ER. To test
the cholesterol dependence of EGF-stimulated ILV formation,
we removed both potential cholesterol sources by culturing cells
in LPDS with or without statin to block cholesterol synthesis
(Goldstein and Brown, 2015). The addition of statin reduced
ILV numbers/MVB by over 40% (Figures 3A and 3B). Statins
act early in the cholesterol biosynthesis pathway (Figure S3A),
also affecting protein prenylation, and potentially therefore Rab
function. However, the effect of statins on ILV formation was
not due to reduced protein prenylation, because addition of
LDL (Figures 3A and 3B) or the cholesterol precursor squalene
(Figures S3A and 3B) reversed the effects of statin treatmentFigure 2. Correlation between Requirements for ER MCSs with EGFR-
(A) HeLa cells were stained for endogenous S100A11 using pre-embedding labelin
arrows) between the ER and MVBs. Scale bar, 200 nm.
(B and C) HeLa cells transfected with non-targeting siRNA (CON) and siRNA targe
anti-EGFR gold and MCSs with EGFR-MVBs (B) and ILVs/EGFR-MVB (C) quant
(D–F) HeLa cells mock transfected (Control) or transfected withWT annexin A1 or a
SD of three experiments. ns, not significant p > 0.05; *p < 0.05, **p < 0.01.
See also Figure S2.on ILV formation. These results demonstrate the cholesterol
dependence of EGF-stimulated ILV formation, which, in the
absence of endocytosed LDL-cholesterol, is derived from
the ER.
Increasing the need for sterol traffic from ER to EGFR-MVBs,
by culturing cells in LPDS, increased the numbers of contacts
between the two organelles (Figure 1B). This led us to ask if
further increasing contacts between ER and EGFR-MVBs leads
to a discernible increase in sterol traffic from the ER to EGFR-
MVBs. We therefore examined whether overexpression of phos-
phomimetic annexin A1, which increases ER contacts with
EGFR-MVBs (Figure 2F), also leads to an increase in free endo-
somal cholesterol in cells cultured in LPDS. Overexpression of
Y21E-annexin A1-gfp increased intracellular filipin staining
compared with gfp-transfected controls (Figure 3C, quantitated
in E), which overlapped with endocytosed EGF (Figure 3C,
quantitated in F). This colocalization was incomplete and pre-
dominantly with the population of EGF-positive endosomes in
perinuclear clusters (Figures 3C and S3C). However, as filipin
staining does not give a discrete signal, to demonstrate the pres-
ence of cholesterol in EGFR-MVBs we also used perfringoly-
sin-O (PFO) to label cholesterol (Kwiatkowska et al., 2014).
PFO is a well-characterized cholesterol-binding toxin (Iwamoto
et al., 1997) that has been extensively used for quantitative
cholesterol analysis (Das et al., 2014; Sokolov and Radhak-
rishnan, 2010) with increased PFO staining in the endocytic or-
ganelles of NPC1-deficient cells reported in several studies (for
example, Kwiatkowska et al., 2014; Sugii et al., 2003). The
PFO fused with glutathione S-transferase used in this study
showed selective and dose-dependent recognition of choles-
terol (Kwiatkowska et al., 2014), and we have confirmed its
suitability as a quantitative cholesterol probe by cryo-immu-
noEM (see Experimental Procedures and Figures S3D and
S3E). Supporting our observations with filipin staining, PFO
immunogold labeling of cryosections of cells cultured in LPDS
revealed an approximately 2-fold increase in PFO staining/
EGFR-MVB in Y21E-annexin A1gfp-expressing cells (Figures
3D and 3G) that have increased MCSs (Figure 2F) compared
with non-expressing controls. To further probe the role of
annexin A1-regulated MCSs in cholesterol transport under these
conditions, we quantified PFO staining in cells depleted of
annexin A1 and cultured in LPDS. Loss of annexin A1 caused
a >4-fold reduction in PFO staining/EGFR-MVBs (Figures 3D,
3G, and S3F), further supporting a role for annexin A1-regulated
MCSs in ER to EGFR-MVB cholesterol transport.
EGF-Stimulated ILV Formation in the Absence of LDL
Requires VAP-ORP1L Interaction
Having established a role for annexin A1-dependent transport of
cholesterol from the ER to EGFR-MVBs in ILV formation, we nextMVBs and ILV Formation
g. Staining (white arrows) is visible on the ER (arrowheads) and at MCSs (black
ting S100A11 (siS100) or incubated with BAPTA were stimulated with EGF and
ified. Data are means ± SD of three experiments. **p < 0.01.
nnexin A1mutants were stimulated and quantified as above. Data aremeans ±
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investigated candidate proteins that could play a role in choles-
terol sensing and/or transfer at the contact. Our observation that
ORP1L depletion, like LDL removal, resulted in increased MCSs
specifically with EGFR-MVBs (Figure 1B) suggested a role for
ORP1L in regulating endosomal sterol levels. This was confirmed
by depletion of ORP1L, which reduced ILV formation in EGFR-
MVBs by 50% in cells cultured in LPDS, an effect that was
reversed by addition of LDL to the medium (Figures 4A and
4B). Since endosomal ORP1L interacts with ER-localized
VAPA under conditions of low LDL-cholesterol, might this inter-
action promote cholesterol transfer from the ER to cholesterol-
depleted EGFR-MVBs at MCSs in a manner analogous to the
VAPA-OSBP-mediated ER to Golgi lipid transport (Mesmin
et al., 2013)? Indeed, the 50% reduction of ILVs induced by
ORP1L depletion was reproduced by depletion of VAPs (Figures
S4A and S4B). This indicates that VAPs and ORP1L are required
for transport of ER-derived cholesterol to support EGF-stimu-
lated ILV formation. To further investigate the importance of
the VAP-ORP1L interaction in ILV formation, we expressed WT
or an FFAT motif mutant ORP1L construct (mutORP1L-gfp)
that cannot bind VAP (Figure S4C) in cells depleted of ORP1L
(Figures S4D–S4F). While WTORP1L expression was sufficient
to reverse the effect of ORP1L depletion on EGF-stimulated
ILV formation, a similar expression level of mutORP1L (Figures
S4F and S4G) failed to correct the ILV phenotype (Figures 4C
and 4D). Consistent with a role for ORP1L in the transport of
ER-derived cholesterol to MVBs that is mediated by annexin
A1-dependent MCSs, we found that the increased intracellular
filipin staining observed on overexpression of Y21E-annexin A1
is blocked by ORP1L depletion (Figures S4H and S4I). ORP1L
is recruited to MVBs by the late endosome marker, Rab7.
How, therefore, can its role in EGF-stimulated ILV formation be
reconciled with our previous observation that the ER forms
MCSs with early EGFR-MVBs where ILV formation begins
(Eden et al., 2010)? To determine whether ORP1L can be de-
tected on EGFR-MVBs we expressed ORP1L-gfp in cells
cultured with LPDS and found that ORP1L overexpression
induced extended ER-MVB contacts (Figure S4J), but these
were primarily with non-EGFR-MVBs (Figure 4E). Importantly,
ORP1L was also present on EGFR-MVBs (Figure 4E) in the pres-
ence or absence of LDL, but only enriched at ER MCSs with
EGFR-MVBs when cultured in the absence of LDL (Figure 4F).
These results demonstrate a role for the ORP1L-VAP interaction
in EGF-stimulated ILV formation. To determine if this interaction
functions in sterol transfer to EGFR-MVBs under conditions of
low LDL-cholesterol, we again expressed the FFAT motif mutantFigure 3. In the Absence of LDL, EGF-Stimulated ILV Formation Depend
EGFR-MVBs
(A and B) HeLa cells cultured overnight in LPDS ± mevastatin (statin) ± LDL wer
ILVs/EGFR-MVB were quantified (B). Data are means ± SD of three experiments
(C, E, and F) HeLa cells transfected with control-GFP plasmid or phosphomimeti
stained for cholesterol. ne, non-expressing cells; *GFP-expressing cells. Scale b
(nonEXP) and cells expressing the control-GFP plasmid (CONgfp) or phosphom
means ± SD of three experiments (E). Colocalization (Mander’s coefficient) betwe
cells expressing Y21E-annexin A1-gfp (F). Data are means ± SD of three experim
(D and G) HeLa cells transfected with Y21E-annexin A1-gfp or siRNA targeting an
and 5 nm-anti-EGFR-gold conjugate. Cryosections were labeled with PFO (10 nm
on ILVs. Scale bar, 200 nm (D). PFO gold/EGFR-MVB was quantified. Data are m
See also Figure S3.ORP1L construct in cells depleted of endogenous ORP1L.
Consistent with a role for ORP1L in cholesterol transport to
EGFR-MVBs under conditions of low endosomal cholesterol,
depletion of ORP1L resulted in an approximately 4-fold reduc-
tion in PFO staining of cholesterol in EGFR-MVBs (Figures 4G
and 4H). However, whereas expression of wtORP1L-gfp
restored PFO labeling to levels comparable with control cells,
mutant ORP1L expression had no effect on cholesterol label in
EGFR-MVBs (Figures 4G and 4H). These data demonstrate the
importance of the VAP-ORP1L interaction at ER-MVB contact
sites for the transport of ER-derived cholesterol to EGFR-
MVBs when cells are cultured in the absence of exogenous LDL.
DISCUSSION
Using EM, which allows unparalleled insights into MCS biology,
we have identified multiple differentially regulated MCSs be-
tween the ER and endocytic organelles. We have demonstrated
a role for VAPs in the regulation of MCSs with lysosomes and
EGFR-negative MVBs. Surprisingly, neither VAPs nor ORP1L
are required for ER MCSs with EGFR-MVBs in the presence of
LDL-cholesterol. Instead these are a biochemically distinct sub-
population of contacts within the endocytic pathway that are
specifically tethered by annexin A1 and its Ca2+-dependent
ligand, S100A11. In vitro studies have shown that a heterote-
tramer of annexin A1 and S100A11 can bridgemembranes alone
(Gerke and Moss, 2002), and both proteins localize to ER con-
tacts with EGFR-MVBs. How these proteins localize specifically
to this subset of contacts is unclear but annexin A1 has been
shown to associate with EGFR (Radke et al., 2004), and we iden-
tified an annexin A1-EGFR association that occurs rapidly after
EGF stimulation and is relatively short-lived. The timing of this
association suggests that it does not have a direct role in MCS
formation, because the role of annexin A1 in MCS formation
persists when the annexin A1-EGFR interaction is no longer
detectable, but it may promote annexin A1 phosphorylation.
Why tyrosine phosphorylation is so important for annexin A1’s
role in MCS and ILV formation is unclear. Whereas the endoso-
mal association of the closely related annexinA2 requires its
tyrosine phosphorylation (Morel and Gruenberg, 2009), endoso-
mal association of annexin A1 appears more dependent on
Ca2+-binding sites than N-terminal phosphorylation (Futter
et al., 1993; Radke et al., 2004; Rescher et al., 2000). A combina-
tion of in vitro and in vivo experiments have suggested that phos-
phorylation of annexin A1 Y21 regulates not only Ca2+ sensitivity
of endosome association (Futter et al., 1993), but also N-terminals on Annexin A1-Dependent Transport of ER-Derived Cholesterol to
e stimulated with EGF and anti-EGFR gold for 30 min. Scale bar, 200 nm (A).
. *p < 0.05, **p < 0.01.
c Y21E-ANXA1gfp were stimulated with fluorescent EGF for 30 min and filipin-
ar, 5 mm (C). Intracellular filipin staining was measured in non-expressing cells
imetic annexin A1 (Y21Egfp) and normalized to non-expressing cells; data are
en EGF and filipin was determined in non-expressing control cells (Control) or
ents. ns, not significant p > 0.05; **p < 0.01, ***p < 0.001.
nexin A1 (siANX) were cultured overnight in LPDS prior to stimulation with EGF
) and GFP (15 nm). Black arrows indicate MCSs. White arrows show PFO label
eans ± SEM (G). **p < 0.01.
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proteolysis (Haigler et al., 1987) and sumoylation in response to
EGF (Hirata et al., 2010). Together these could regulate protein-
protein interactions and, thereby, MCS formation and stability.
Interestingly expression of phosphomimetic Y21E-annexin A1
caused the greatest increase in MCS formation, but was less
effective than WT annexin A1 at promoting ILV formation.
Dephosphorylation of annexin A1 may have a role in MCS disas-
sembly, which may be important to allow ILVs to detach from the
MVB-limiting membrane. Although the dependence on EGF-
stimulated phosphorylation suggests a specific requirement for
annexin A1 in MCSs between the ER and EGFR-MVBs, a role
for the closely related endosome-localized annexin A2 in other
classes of MCS between the ER and endocytic pathway cannot
be excluded.
That annexin A1-regulated MCSs allow PTP1B to interact with
endosomal targets, including ESCRT0 (Eden et al., 2010; Stuible
et al., 2010), provides a likely mechanism underlying annexin
A1’s role in ILV formation and emphasizes the importance of
resolving the functional significance of ESCRT phosphoryla-
tion/dephosphorylation. Importantly, we find that annexin
A1-regulated MCSs perform a dual role in ILV formation. Not
only are they platforms for PTP1B-mediated effects at the endo-
some, but they also are required for the transport of ER-derived
cholesterol to MVBs when endosomal cholesterol is low. A key
finding of this study is that cholesterol is required for EGF-stim-
ulated ILV formation. Interestingly, the ESCRT0 component, Hrs,
which promotes ILV formation, has also been implicated in sterol
sorting, and a role for Hrs in sorting cholesterol onto microdo-
mains on the limiting membrane was proposed (Du et al.,
2012). ESCRTII complexes have been shown to induce phase-
separated microdomains that depend on cholesterol (Boura
et al., 2012). Cholesterol-rich microdomains might initiate inward
budding into the lumen of the MVB as the ILV begins to form, as
has been found at the yeast vacuole (Wang et al., 2014).
ER MCSs have been implicated in specific lipid transfer steps
at the Golgi, plasma membrane, and mitochondria (Lahiri et al.,
2015). Transport of LDL-cholesterol from the endosome to the
ER at MCSs has previously been proposed (Du et al., 2011;
Raiborg et al., 2015b; van der Kant and Neefjes, 2014). In
contrast, ER-endosome MCSs have never before been impli-
cated in the transport of ER-derived cholesterol in the reverse
direction, from the ER to endosomes. Here we demonstrate
transport of ER-derived cholesterol to MVBs to supportFigure 4. In the Absence of LDL, EGF-Stimulated ILV Formation Depen
(A and B) HeLa cells transfected with a non-targeting siRNA (siCON) or siRNA targ
with EGF and anti-EGFR gold. Scale bar, 200 nm (A). The number of ILVs/EGFR
***p < 0.001.
(C and D) HeLa cells depleted of ORP1L (siORP1L) were transfected with wtORP1
overnight in LPDS and stimulated with EGF and anti-EGFR gold (EGFR-Au). Scale
shown as means ± SD of three experiments (D). ns, not significant p > 0.05; ***p
(E and F) HeLa cells transfected with ORP1L-gfp were cultured overnight in LPD
embedding labeling (E). ORP1L-gfp staining (white arrows) was observed on EG
MCSs (black arrows) with the ER (arrowheads) and was associated with extende
MVB MCSs ± LDL was quantified (F). Data are means ± SD. **p < 0.01.
(G and H) HeLa cells transfected with non-targeting siRNA (siCON) or siRNA ta
mutant ORP1L-gfp (mutORP1L) and cultured overnight in LPDS prior to stimulat
with PFO (10 nm) andGFP (15 nm). Black arrows showMCSs.White arrows show
MVB were quantified. Data are means ± SEM (H). ns, not significant p > 0.05; *p
See also Figure S4.EGF-stimulated ILV formation, which requires the ORP1L-VAP
interaction at MCSs when endosomal cholesterol is low. The
Rab7-dependence of ORP1L recruitmentmeans that it is primar-
ily recruited to late endosomes and lysosomes. Annexin
A1-MCSs form with both early and late endosomes that are
defined not by their maturity but by the presence of EGFR.
A Rab5 to Rab7 switch accompanies MVB maturation (Rink
et al., 2005) but, consistent with our demonstration of ORP1L
recruitment to EGFR-MVBs, both Rab5- and Rab7-positive
MVBs can contain EGFR. The recruitment of increasing levels
of ORP1L during MVB maturation allows a fundamental part of
the MVB maturation process, ILV formation, to complete, even
under conditions of low LDL-cholesterol.
A recent study in yeast identified an ER-anchored sterol
transfer protein that is able to transfer sterols in vitro and to
promote ergosterol-enriched domains that invaginate into
the vacuole (Murley et al., 2015). Our finding of a role for an-
nexin A1-regulated MCSs in the transport of ER-derived
cholesterol to MVBs is the first evidence that ER-endosome
MCSs function in lipid transport in mammalian cells. This
transport requires ORP1L interaction with VAPs, which only
occurs in low-cholesterol conditions (Rocha et al., 2009). In
the absence of either LDL-cholesterol or ORP1L, MCS forma-
tion with EGFR-MVBs is increased, indicating that when LDL-
cholesterol is present it is sensed by ORP1L, which limits
MCS formation. How MCS size is regulated and the role of
ORP1L in this process are yet to be determined. It is worth
noting that MCSs between EGFR-MVBs and the ER have to
be dynamically regulated to allow for localized disassembly
before ILVs pinch off from the limiting membrane (to prevent
ER from entering the invaginating vesicle). In the absence of
LDL-cholesterol ORP1L binds VAP, and this interaction pro-
motes cholesterol transfer from the ER to MVBs to support
ILV formation. How the ORP1L-VAP interaction promotes
cholesterol transfer remains to be resolved but it could func-
tion similarly to the OSBP-mediated ER to Golgi sterol transfer
that is coupled to reverse transport of PI(4)P from the Golgi to
the ER (Mesmin et al., 2013). A similar sterol-phosphoinositide
exchange could also occur at ER-endosome contacts, with a
pool of endosomal PI(4)P recently identified (Hammond et al.,
2014). While direct sterol transfer at the MCS is the most likely
explanation for our data, ORP1L effects on endosomal posi-
tioning could affect indirect sterol transport (via the plasmads on Interaction between VAPs and ORP1L
eting ORP1L (siORP1L) were cultured overnight in LPDS ± LDL and stimulated
-MVB was quantified and data shown as mean ± SD of three experiments (B).
L-gfp or an FFATmotif mutant ORP1L-gfp construct (mutORP1L-gfp), cultured
bar, 200 nm (C). The number of ILVs/EGFR-MVB was quantified and data are
< 0.001.
S ± LDL, stimulated with EGF-HRP (30 min) and stained for GFP using pre-
FR-MVBs (containing electron-dense EGF-HRP/DAB reaction product) and at
d MCSs in non-EGFR-MVBs. Scale bar, 200 nm (E). ORP1L labeling at EGFR-
rgeting ORP1L (siORP1L) were transfected with wtORP1L-gfp or FFAT motif
ion with EGF and 5 nm-anti-EGFR-gold conjugate. Cryosections were labeled
PFO label within EGFR-MVBs. Scale bar, 200 nm (G). PFO gold particles/EGFR-
< 0.05, **p < 0.01.
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membrane), as ORP1L-VAP interactions increase peripheral
positioning of endosomes by disrupting their association
with minus-end directed microtubule motors (Rocha et al.,
2009).
Our identification of key regulators of ER-endosomeMCSswill
enable the role of contact sites in lipid exchange between the
endocytic pathway and the ER to be further explored. Transport
of ER-derived cholesterol to MVBs ensures that EGF-stimulated
ILV formation proceeds to completion, even when LDL-choles-
terol in the endocytic pathway is low, as found for example in
cells from familial hypercholesterolemia patients carrying muta-
tions that prevent LDL uptake (Soutar andNaoumova, 2007). The
evolution of such a mechanism underscores the importance of
ILV formation for the spatial regulation of receptor tyrosine ki-
nase signaling.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HeLa cells were cultured in DMEM/10% fetal bovine serum (Invitrogen). Cells
were transfected using Lipofectamine LTX Plus for plasmids and Lipofect-
amine RNAiMax (Invitrogen) for small interfering RNAs (siRNAs), according
to the manufacturer’s instructions.
Antibodies, Plasmids, and siRNAs
A complete description is provided in the Supplemental Experimental
Procedures.
Electron Microscopy
Conventional and cryo-immunoEM were performed essentially as
described (Eden et al., 2010) but with modifications detailed in Supple-
mental Experimental Procedures. EGFR-MVBs were distinguished from
non-EGFR-MVBs by anti-EGFR gold particles and lysosomes were identi-
fied by multilamellar whorls. Apposing membranes at ER-MVB MCSs were
<30 nm apart, with no minimum MCS length. MCS quantitation in random
sections used methods validated by serial sectioning (Figure S1A), with
>200 endocytic organelles/condition imaged over three experiments. For
quantitation of ILVs or MCSs/EGFR-MVB, R100 EGFR-MVBs per condi-
tion were imaged by EM over three experiments. For quantitation of PFO
label, 10 nm PFO gold was counted in EGFR-MVBs and SEM calculated
in Microsoft Excel. For quantitation of ORP1L label at EGFR-MVB MCSs,
cells were stimulated with EGF-horseradish peroxidase before fixation
and 3,3-diaminobenzidine reaction. The number of ER MCSs with EGFR-
MVB that are positive for ORP1L-gfp were counted in cells cultured over-
night in LPDS ± LDL. For further details see Supplemental Experimental
Procedures.
Florescence Imaging
Immunofluorescence was essentially as previously described (Eden et al.,
2010) with modifications as described in Supplemental Experimental
Procedures.
Western Blotting, Immunoprecipitation, and Quantitative RT-PCR
Described in full in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2016.05.005.
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